Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Saved in:
| Title: | Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. |
|---|---|
| Authors: | Luszczak S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Simpson BS; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Sathyadevan VK; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Echeverria LMC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Kumar C; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Costa H; Research Department of Pathology, University College London, London, UK., Haider A; Research Department of Pathology, University College London, London, UK., Freeman A; Research Department of Pathology, University College London, London, UK., Jameson C; Research Department of Pathology, University College London, London, UK., Ratynska M; Research Department of Pathology, University College London, London, UK., Ben-Salha I; Research Department of Pathology, University College London, London, UK., Sridhar A; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK., Shaw G; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK., Kelly JD; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK., Pye H; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Gately KA; Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Ireland., Whitaker HC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk. |
| Source: | Scientific reports [Sci Rep] 2020 Sep 01; Vol. 10 (1), pp. 14380. Date of Electronic Publication: 2020 Sep 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32873828 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Luszczak+S%22">Luszczak S</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Simpson+BS%22">Simpson BS</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Stopka-Farooqui+U%22">Stopka-Farooqui U</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sathyadevan+VK%22">Sathyadevan VK</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Echeverria+LMC%22">Echeverria LMC</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Kumar+C%22">Kumar C</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Costa+H%22">Costa H</searchLink>; Research Department of Pathology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Haider+A%22">Haider A</searchLink>; Research Department of Pathology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Freeman+A%22">Freeman A</searchLink>; Research Department of Pathology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Jameson+C%22">Jameson C</searchLink>; Research Department of Pathology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ratynska+M%22">Ratynska M</searchLink>; Research Department of Pathology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ben-Salha+I%22">Ben-Salha I</searchLink>; Research Department of Pathology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sridhar+A%22">Sridhar A</searchLink>; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Shaw+G%22">Shaw G</searchLink>; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Kelly+JD%22">Kelly JD</searchLink>; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Pye+H%22">Pye H</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Gately+KA%22">Gately KA</searchLink>; Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Ireland.<br /><searchLink fieldCode="AU" term="%22Whitaker+HC%22">Whitaker HC</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Heavey+S%22">Heavey S</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2020 Sep 01; Vol. 10 (1), pp. 14380. <i>Date of Electronic Publication: </i>2020 Sep 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32873828 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-020-71263-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 14380 Titles: – TitleFull: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Luszczak S – PersonEntity: Name: NameFull: Simpson BS – PersonEntity: Name: NameFull: Stopka-Farooqui U – PersonEntity: Name: NameFull: Sathyadevan VK – PersonEntity: Name: NameFull: Echeverria LMC – PersonEntity: Name: NameFull: Kumar C – PersonEntity: Name: NameFull: Costa H – PersonEntity: Name: NameFull: Haider A – PersonEntity: Name: NameFull: Freeman A – PersonEntity: Name: NameFull: Jameson C – PersonEntity: Name: NameFull: Ratynska M – PersonEntity: Name: NameFull: Ben-Salha I – PersonEntity: Name: NameFull: Sridhar A – PersonEntity: Name: NameFull: Shaw G – PersonEntity: Name: NameFull: Kelly JD – PersonEntity: Name: NameFull: Pye H – PersonEntity: Name: NameFull: Gately KA – PersonEntity: Name: NameFull: Whitaker HC – PersonEntity: Name: NameFull: Heavey S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2020 Sep 01 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |